The Conduct of Clinical Trials
Multicenter Clinical Cancer Research After COVID-19: A Perspective From NRG Oncology

https://doi.org/10.1016/j.ijrobp.2020.06.056Get rights and content

Cited by (0)

This project was supported by grants U10CA180868 (NRG Oncology Operations), U10CA180822 (NRG Oncology SDMC), and UG1CA189867 (NCORP) from the National Cancer Institute.

Disclosures: M.F.G. reports grants from Varian Medical Systems and Philips Healthcare and other from Roche, outside the submitted work. Q.T.L. reports grants from NCI to NRG Oncology for a role as HNC committee chair of NRG Oncology, during the conduct of the study. M.M. reports honoraria, travel, and research funding from AstraZeneca, Varian, Elekta, and ViewRay, outside the submitted work. S.S.Y. reports grants from Genentech, Bristol-Myers Squibb, Merck, and BioMimetix; personal fees (book royalty) from Springer;and personal fees from UpToDate (chapter royalty), outside the submitted work.

View Abstract